Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection.

Authors :: Mehrabi Z
Salimi M
Niknam K
Mohammadi F
Mamaghani HJ
Sasani MR
Ashraf MJ
Salimi A
Zahedroozegar MH
Erfani Z
Source :: Case reports in ophthalmological medicine [Case Rep Ophthalmol Med] 2021 Oct 28; Vol. 2021, pp. 9745701. Date of Electronic Publication: 2021 Oct 28 (Print Publication: 2021).
Publication Year :: 2021
Abstract: Background: Mucormycosis is a rare and invasive fungal infection, affecting almost exclusively immunocompromised individuals. Immunosuppressive effects of corticosteroids which are widely prescribed in COVID-19 patients might be a predisposing factor for opportunistic infections even though the other factors should also be considered. Case Presentation . A middle-aged man without any significant past medical history was admitted to the hospital due to a severe COVID-19 infection. He received a high dose of corticosteroids as a part of the treatment. Five days after discharge, he presents with a headache and fever. Eventually, orbital mucormycosis was diagnosed for him and he was treated with antifungal medications.<br />Conclusion: Opportunistic infections should be considered during the current pandemic of COVID-19, during which corticosteroids are widely prescribed.<br />Competing Interests: The authors declare that they have no competing interests.<br /> (Copyright © 2021 Zeinab Mehrabi et al.)

Full Text Access

Tools